blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0408370

EP0408370 - Stable tretinoin emulsified cream formulations [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.07.1996
Database last updated on 24.04.2024
Most recent event   Tooltip28.11.2003Lapse of the patent in a contracting state
New state(s): ES
published on 14.01.2004  [2004/03]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [1995/37]For all designated states
Bristol-Myers Squibb Company
345 Park Avenue
New York, N.Y. 10154 / US
Former [1991/03]For all designated states
Bristol-Myers Company
345 Park Avenue
New York New York 10154 / US
Inventor(s)01 / Parab, Prakash
267 Patton Place
Williamsville, New York 14221 / US
[1991/03]
Representative(s)Jones, Alan John, et al
CARPMAELS & RANSFORD 43 Bloomsbury Square
London, WC1A 2RA / GB
[N/P]
Former [1991/03]Jones, Alan John, et al
CARPMAELS & RANSFORD 43 Bloomsbury Square
London, WC1A 2RA / GB
Application number, filing date90307656.012.07.1990
[1991/03]
Priority number, dateUS1989037929413.07.1989         Original published format: US 379294
US1989045364020.12.1989         Original published format: US 453640
[1991/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0408370
Date:16.01.1991
Language:EN
[1991/03]
Type: A3 Search report 
No.:EP0408370
Date:13.03.1991
Language:EN
[1991/11]
Type: B1 Patent specification 
No.:EP0408370
Date:13.09.1995
Language:EN
[1995/37]
Search report(s)(Supplementary) European search report - dispatched on:EP23.01.1991
ClassificationIPC:A61K9/10, A61K31/07
[1991/03]
CPC:
A61K31/07 (EP,KR); A61K47/10 (EP); A61K8/342 (EP);
A61K8/671 (EP); A61K9/0014 (EP); A61K9/06 (KR);
A61P17/00 (EP); A61Q19/00 (EP); A61Q19/08 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/03]
TitleGerman:Stabile emulgierte Tretinoin-Cremeformulierungen[1991/03]
English:Stable tretinoin emulsified cream formulations[1991/03]
French:Formulations de crème trétinoine émulsifiée stable[1991/03]
Examination procedure19.08.1991Examination requested  [1991/42]
21.05.1992Despatch of a communication from the examining division (Time limit: M06)
27.11.1992Reply to a communication from the examining division
07.06.1993Despatch of a communication from the examining division (Time limit: M06)
06.12.1993Reply to a communication from the examining division
21.04.1994Despatch of a communication from the examining division (Time limit: M04)
18.08.1994Reply to a communication from the examining division
10.10.1994Despatch of communication of intention to grant (Approval: Yes)
17.02.1995Communication of intention to grant the patent
16.03.1995Fee for grant paid
16.03.1995Fee for publishing/printing paid
Opposition(s)14.06.1996No opposition filed within time limit [1996/36]
Fees paidRenewal fee
09.07.1992Renewal fee patent year 03
12.07.1993Renewal fee patent year 04
07.07.1994Renewal fee patent year 05
11.07.1995Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT13.09.1995
BE13.09.1995
CH13.09.1995
DK13.09.1995
GR13.09.1995
LI13.09.1995
NL13.09.1995
SE13.12.1995
ES24.12.1995
[2004/03]
Former [2003/07]AT13.09.1995
BE13.09.1995
CH13.09.1995
DK13.09.1995
GR13.09.1995
LI13.09.1995
NL13.09.1995
SE13.12.1995
Former [2000/04]AT13.09.1995
BE13.09.1995
CH13.09.1995
DK13.09.1995
GR13.09.1995
LI13.09.1995
SE13.12.1995
Former [1998/15]AT13.09.1995
BE13.09.1995
CH13.09.1995
DK13.09.1995
LI13.09.1995
SE13.12.1995
Former [1997/13]AT13.09.1995
BE13.09.1995
CH13.09.1995
LI13.09.1995
SE13.12.1995
Former [1996/28]AT13.09.1995
BE13.09.1995
SE13.12.1995
Former [1996/23]BE13.09.1995
SE13.12.1995
Former [1996/22]BE13.09.1995
Documents cited:Search[XD]GB906000  (HOFFMANN LA ROCHE);
 [XD]US3906108  (FELTY LANNY G);
 [A]US3966967  (LEE KWAN-HUA);
 [XD]GB1466062  (KNIGHT K);
 [AD]US4727088  (SCOTT RICHARD A [US], et al);
 [XP]EP0350438  (HERZOG PAUL [CH], et al)
Examination   - USAN and the USP Dictionary of Drug Names,p.613
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.